Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page history.
    Difference
    0.1%
    Check dated 2026-03-11T17:14:43.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.4.2) and removed an older notice about government funding/operating status (v3.4.1) from the history page.
    Difference
    0.4%
    Check dated 2026-02-11T01:47:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice banner was added and the page revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T22:40:15.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates on the history page introduce a glossary display, color-coded additions and deletions, and an updated revision label (for example Revision: v3.4.0).
    Difference
    0.6%
    Check dated 2026-01-27T17:36:03.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The Version History shows a new Revision v3.3.4 added and Revision v3.3.3 removed, reflecting administrative updates to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T14:12:53.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Footer updates show the site revision updated to v3.3.3 and the HHS Vulnerability Disclosure link removed, which are administrative UI changes not affecting the trial record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-22T01:53:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.